ARCHIVES

NCI selects nanotech centers for funding.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

October 10, 1980

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

February 2, 1996